EU to stockpile key drugs to avoid repeat of pandemic-era panic buying
Member states agree on Critical Medicines Act that aims to incentivise domestic production
Related reading
EU trims exclusivity window for new drugs
Cheaper generics will be allowed on to market a year earlier to curb costs
Europe is risking ‘health sovereignty’ by underpaying for drugs, says…
CEO warns continent’s advantage in the industry could fade as companies build new high-tech factories elsewhere
NHS to increase medicines spending to avoid threatened Trump tariffs
UK government will make it easier for drugs to be approved for use in order to secure carve-out from import levies
US drugmakers threaten to withhold products from Europe over prices
Pharmaceutical companies seek to make up any lost revenue after striking deals with Donald Trump to lower costs in US
UK urges pharma companies to invest after reaching drug pricing deal with US
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
US readies new pharmaceutical tariffs
Levies of 100% on certain medicines would implement threats Trump made last year